NanoSphere Health Sciences Inc. (NSHS.CN)
CAD 0.05
(0.0%)
CAD 0.05
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -228.13 USD | 99.92% |
| 2022 | -277.5 Thousand USD | 21.65% |
| 2021 | -354.16 Thousand USD | 42.58% |
| 2020 | -616.81 Thousand USD | 82.32% |
| 2019 | -3.48 Million USD | 22.71% |
| 2018 | -4.51 Million USD | 54.44% |
| 2017 | -9.9 Million USD | -1512.16% |
| 2016 | -614.68 Thousand USD | -360.03% |
| 2015 | -133.61 Thousand USD | 39.17% |
| 2014 | -219.63 Thousand USD | 96.59% |
| 2013 | -6.45 Million USD | -72.88% |
| 2012 | -3.73 Million USD | 58.79% |
| 2011 | -9.05 Million USD | -4501.81% |
| 2010 | -196.71 Thousand USD | -221.22% |
| 2009 | 162.27 Thousand USD | 103.14% |
| 2008 | -5.16 Million USD | -435.54% |
| 2007 | -965.34 Thousand USD | -2998.46% |
| 2006 | -31.15 Thousand USD | -22.82% |
| 2005 | -25.36 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -41.29 Thousand USD | -75054.25% |
| 2024 Q2 | -61.05 Thousand USD | -47.86% |
| 2023 Q3 | -41.47 Thousand USD | 46.93% |
| 2023 Q2 | -78.15 Thousand USD | -46.88% |
| 2023 Q1 | -53.2 Thousand USD | -12.12% |
| 2023 Q4 | -54.94 USD | 99.87% |
| 2023 FY | -228.13 USD | 99.92% |
| 2022 Q2 | -90.31 Thousand USD | -35.28% |
| 2022 FY | -277.5 Thousand USD | 21.65% |
| 2022 Q4 | -47.45 Thousand USD | 8.88% |
| 2022 Q3 | -52.08 Thousand USD | 42.33% |
| 2022 Q1 | -66.75 Thousand USD | -135.6% |
| 2021 FY | -354.16 Thousand USD | 42.58% |
| 2021 Q1 | -66.63 Thousand USD | 62.87% |
| 2021 Q2 | -127.3 Thousand USD | -91.05% |
| 2021 Q3 | -349.83 Thousand USD | -174.81% |
| 2021 Q4 | 187.5 Thousand USD | 153.6% |
| 2020 Q1 | -235.28 Thousand USD | 82.48% |
| 2020 Q2 | -111.64 Thousand USD | 52.55% |
| 2020 Q3 | -64.83 Thousand USD | 41.93% |
| 2020 Q4 | -179.46 Thousand USD | -176.82% |
| 2020 FY | -616.81 Thousand USD | 82.32% |
| 2019 FY | -3.48 Million USD | 22.71% |
| 2019 Q4 | -1.34 Million USD | -54.1% |
| 2019 Q3 | -871.32 Thousand USD | -65.73% |
| 2019 Q2 | -525.75 Thousand USD | 27.88% |
| 2019 Q1 | -728.95 Thousand USD | 64.59% |
| 2018 Q2 | -809.28 Thousand USD | 18.68% |
| 2018 FY | -4.51 Million USD | 54.44% |
| 2018 Q4 | -2.05 Million USD | -215.88% |
| 2018 Q3 | -651.69 Thousand USD | 19.47% |
| 2018 Q1 | -995.18 Thousand USD | 89.75% |
| 2017 Q1 | -69.27 Thousand USD | 19.22% |
| 2017 FY | -9.9 Million USD | -1512.16% |
| 2017 Q4 | -9.71 Million USD | -10805.63% |
| 2017 Q3 | -89.05 Thousand USD | -173.52% |
| 2017 Q2 | -32.55 Thousand USD | 53.0% |
| 2016 Q1 | -16.38 Thousand USD | 52.52% |
| 2016 FY | -614.68 Thousand USD | -360.03% |
| 2016 Q3 | -463.93 Thousand USD | -835.36% |
| 2016 Q2 | -49.6 Thousand USD | -202.75% |
| 2016 Q4 | -85.75 Thousand USD | 81.52% |
| 2015 Q2 | -39.1 Thousand USD | -4.49% |
| 2015 Q4 | -34.5 Thousand USD | -24.95% |
| 2015 Q3 | -27.61 Thousand USD | 29.38% |
| 2015 FY | -133.61 Thousand USD | 39.17% |
| 2015 Q1 | -37.42 Thousand USD | -124.86% |
| 2014 Q4 | 150.55 Thousand USD | 163.18% |
| 2014 Q1 | -75.87 Thousand USD | 93.07% |
| 2014 FY | -219.63 Thousand USD | 96.59% |
| 2014 Q2 | -59.39 Thousand USD | 21.72% |
| 2014 Q3 | -238.28 Thousand USD | -301.17% |
| 2013 Q3 | -480.76 Thousand USD | 89.22% |
| 2013 Q4 | -1.09 Million USD | -127.79% |
| 2013 FY | -6.45 Million USD | -72.88% |
| 2013 Q1 | -330.67 Thousand USD | 62.91% |
| 2013 Q2 | -4.45 Million USD | -1248.45% |
| 2012 FY | -3.73 Million USD | 58.79% |
| 2012 Q2 | -1.08 Million USD | -5.73% |
| 2012 Q3 | -672.86 Thousand USD | 37.93% |
| 2012 Q4 | -891.43 Thousand USD | -32.48% |
| 2012 Q1 | -1.02 Million USD | 85.3% |
| 2011 FY | -9.05 Million USD | -4501.81% |
| 2011 Q4 | -6.97 Million USD | -1120.1% |
| 2011 Q2 | -698.24 Thousand USD | 23.68% |
| 2011 Q1 | -914.89 Thousand USD | -1093.12% |
| 2011 Q3 | -571.48 Thousand USD | 18.15% |
| 2010 FY | -196.71 Thousand USD | -221.22% |
| 2010 Q4 | -76.68 Thousand USD | -59.13% |
| 2010 Q3 | -48.18 Thousand USD | -22.56% |
| 2010 Q2 | -39.31 Thousand USD | -22.59% |
| 2010 Q1 | -32.07 Thousand USD | -268.95% |
| 2009 Q1 | -35.03 Thousand USD | -102.63% |
| 2009 Q2 | -47.04 Thousand USD | -34.28% |
| 2009 Q3 | 235.77 Thousand USD | 601.2% |
| 2009 Q4 | 18.98 Thousand USD | -91.95% |
| 2009 FY | 162.27 Thousand USD | 103.14% |
| 2008 Q2 | -163.72 Thousand USD | -83.53% |
| 2008 Q3 | -6.26 Million USD | -3723.63% |
| 2008 FY | -5.16 Million USD | -435.54% |
| 2008 Q4 | 1.33 Million USD | 121.32% |
| 2008 Q1 | -89.2 Thousand USD | 94.75% |
| 2007 Q1 | -2091.71 USD | 85.71% |
| 2007 Q3 | -251.71 Thousand USD | -371.64% |
| 2007 Q4 | -1.69 Million USD | -574.49% |
| 2007 Q2 | -53.37 Thousand USD | -2451.53% |
| 2007 FY | -965.34 Thousand USD | -2998.46% |
| 2006 Q3 | -3013.61 USD | 20.62% |
| 2006 Q1 | -9302.62 USD | -156.62% |
| 2006 FY | -31.15 Thousand USD | -22.82% |
| 2006 Q2 | -3796.45 USD | 59.19% |
| 2006 Q4 | -14.64 Thousand USD | -385.84% |
| 2005 Q4 | -3625.09 USD | 83.49% |
| 2005 Q3 | -21.95 Thousand USD | 0.0% |
| 2005 FY | -25.36 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -6.78 Million CAD | 99.997% |
| Asep Medical Holdings Inc | -8.22 Million CAD | 99.997% |
| BetterLife Pharma Inc. | -2.88 Million CAD | 99.992% |
| BioVaxys Technology Corp. | -7.68 Million CAD | 99.997% |
| ChitogenX Inc. | -1.55 Million CAD | 99.985% |
| Rapid Dose Therapeutics Corp. | -4.3 Million CAD | 99.995% |
| Defence Therapeutics Inc. | -13.19 Million CAD | 99.998% |
| Entheon Biomedical Corp. | -300 Thousand CAD | 99.924% |
| Gemina Laboratories Ltd. | -5.21 Million CAD | 99.996% |
| Glow Lifetech Corp. | -1.64 Million CAD | 99.986% |
| Lexston Life Sciences Corp. | -867.71 Thousand CAD | 99.974% |
| Pharmala Biotech Holdings Inc. | -779.81 Thousand CAD | 99.971% |
| Doseology Sciences Inc. | -339.84 Thousand CAD | 99.933% |
| MYND Life Sciences Inc. | -1.51 Million CAD | 99.985% |
| Nova Mentis Life Science Corp. | -1.22 Million CAD | 99.981% |
| PharmaTher Holdings Ltd. | -3.11 Million CAD | 99.993% |
| PreveCeutical Medical Inc. | -1.27 Million CAD | 99.982% |
| Telescope Innovations Corp. | -5.72 Million CAD | 99.996% |